CLINICAL_TRIALS
trial_result
· 2021-10-01
Clinical Trial Update: A Study of TG103 Injection in Overweight/Obese Subjects With Type 2 Diabetes [Phase 2]
Summary
Phase 2 clinical trial update for TG103 Injection in overweight/obese subjects with Type 2 Diabetes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: UNKNOWN